Clinical Study to Evaluate the Performance of Magna Ease Heart Valve in Chinese Patients

Edwards Lifesciences

Status: Terminated

Conditions: Mitral Valve or Aortic Valve Replacement

Treatments: Device: Magna Ease

Study type: Observational

Funder types: Industry

Identifiers

NCT02523066

Magna Ease CN001

Details and patient eligibility

About

Clinical Study to Evaluate the Performance of Magna Ease Heart Valve in Chinese patients.

Enrollment: 215 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• The patients who implanted with Magna Ease Heart Valve (Type:7300TFX and 3300TFX) in Fuwai Hospital in China.
• The patients agree to sign the inform consent form (ICF).

Exclusion criteria

• No specific exclusion criteria.

Trial design

215 participants in 1 patient group

Mitral Valve or Aortic Valve Replancement

Description:

One-arm group

Treatment:

Device: Magna Ease